Skip to main content
Annals of Medicine and Surgery logoLink to Annals of Medicine and Surgery
. 2022 Jan 3;73:103226. doi: 10.1016/j.amsu.2021.103226

Sepsis and disseminated intravascular coagulation are rare complications of typhoid fever: A case report

Nurnaningsih 1,, Vincencius William 1, Desy Rusmawatiningtyas 1, Firdian Makrufardi 1, Intan Fatah Kumara 1
PMCID: PMC8767294  PMID: 35079365

Abstract

Introduction

and importance: Typhoid fever is an infection caused by Salmonella typhi. The common complications are intestinal perforation and typhoid encephalopathy. Cases of typhoid fever with sepsis and/or disseminated intravascular coagulation (DIC) are rarely reported, even though typhoid fever is endemic in Indonesia.

Case presentation

A 4-year-old male referral case from a district hospital was experiencing fever, decrease of consciousness and massive bleeding from his gastrointestinal tract and nose. Investigation revealed results from the IgM typhoid test using Tubex®TF, with the score of +8. PELOD 2 score was 10, and PSOFA was 5. DIC score was 7. Based on these findings, the patient was diagnosed with typhoid fever, with DIC and sepsis being the complication of the typhoid fever.

Clinical discussion

DIC is mostly a subclinical event, and severe bleeding complications found in typhoid fever are uncommon, although DIC scores which indicate an imbalance of coagulation and fibrinolysis are markedly elevated in patients with typhoid. DIC can be a part of multi-organ dysfunction due to sepsis syndrome. Acute infection can also result in systemic activation of coagulation.

Conclusion

Sepsis and DIC are rare complications of typhoid fever. Typhoid fever can be presented with profound bleeding manifestation other than gastrointestinal bleeding, since it is a common symptom of typhoid fever. Further research should be conducted to postulate association between typhoid fever and DIC.

Keywords: Typhoid fever, Disseminated intravascular coagulation, Sepsis, Pediatric, Case report

Highlights

  • Sepsis and DIC are rare complications of typhoid fever.

  • Typhoid fever can be presented with profound bleeding manifestation.

  • Acute infection can also result in systemic activation of coagulation.

1. Introduction

Typhoid fever is an infection that is mainly transmitted orally through food or water contaminated with Salmonella typhi. There are an estimated 11–21 million cases of typhoid fever and approximately 128,000–161,000 deaths annually, with the majority of the cases occurring in South Asia, South East Asia, and Sub-Saharan Africa [1]. Common symptoms are fever, with digestive symptoms such as abdominal pain, diarrhea, and bloody stool. Non-specific symptom profile complicates clinical diagnosis, with symptoms that are common to other diseases occurring in typhoid-endemic areas. The mainstay for laboratory confirmation is blood culture, but this has limited sensitivity of approximately 40–60%, due to the window period for detecting organisms circulating in the bloodstream being usually early in the course of the disease and particularly in the first week of the illness, as well as widespread use of antimicrobials [2]. Cases of typhoid fever with disseminated intravascular coagulation (DIC) are rarely reported, even though typhoid fever is endemic in Indonesia [3]. Here, we present a case of a patient with typhoid fever, sepsis and DIC in our low-resource setting. This case was reported in line with the Surgical CAse REport (SCARE) criteria [4].

2. Case presentation

A 4-year-old male referral case from a district hospital was experiencing fever, decreased level of conscious, and massive bleeding from his gastrointestinal tract and nose. The patient had been born spontaneously, full term, without history of any underlying disease. None of his parents and siblings have coagulation problems.

Eleven days before admission to Dr. Sardjito Hospital, the patient experienced a fever and cough. The patient was taken to a community health center and assessed with an upper respiratory tract infection. He was treated with acetaminophen and antimicrobial agent, but there was no clinical improvement. Five days before admission, he was referred by a community health center to a district hospital with a suspected diagnosis of dengue fever due to fever and thrombocytopenia, platelet level was 90,000 cells/μL.

Patient was hospitalized in the district hospital for five days, while the fever still persisted. During his hospitalization there was diarrhea, melena, and a hypovolemic shock on the fourth day of admission which was successfully treated with fluid resuscitation. Laboratory examination revealed that there was thrombocytopenia (the lowest level of platelet was 67,000 cells/μL), and leukopenia (2,600 cells/μL). Patient was diagnosed with dengue hemorrhagic fever with unspecified secondary infection. He was treated with antimicrobial agent, acetaminophen, omeprazole, fluid therapy, and platelet transfusion. Antimicrobial therapy that was given included ceftriaxone for 3 days, which was switched to ampicillin-sulbactam on the fourth day of hospitalization, and switched again with ceftazidime on fifth day of hospitalization. Patient had been given 10 L of intravenous fluid using ringer lactate for five days which caused edema. Patient was referred to our hospital, Dr. Sardjito Hospital, due to decrease of consciousness, history of shock and no improvement in clinical symptoms.

The patient's body weight was 22.0 kg, and height 101.0 cm. He was obese based on the weight for height ratio. His general condition was apathetic; his temperature was 37.4 °C. Glasgow Coma Scale was E2 M4 V1, isochoric pupil with normal pupillary light reflex. His heart rate was 160 beats/minutes, blood pressure measured 153/108 mmHg (>95th percentile), good peripheral pulse and capillary refill time less than 2 seconds. Respiratory rate was 64 times/minutes, and oxygen saturation was 87% with rebreathing mask 12 L per minute. His breathing sounds were vesicular and rhonchi in both lungs. Physical examination revealed that his abdomen was distended, with decreasing abdominal sound and ascites. Liver was palpated 9 cm below the right hypochondrium, indicating hepatomegaly. No lymphadenopathy was identified. Massive bleeding was indicated from nasal bleeding, nasogastric tube bleeding, and melena.

Initial laboratory examination found thrombocytopenia (75,000 cells/μL), increase of transaminase enzyme (ALT 4,668 U/L, AST 616 U/L), abnormal blood coagulation (PPT 40.3 s, aPTT 83.8 s, Fibrinogen <7 mg/dL, D-dimer 10,400 ng/mL), lactatemia (lactate 5.42 mg/dL), and increased level of procalcitonin (procalcitonin 11.98 ng/ml) (Table 1). DIC score was 7 from thrombocytopenia. Urinalysis was normal. IgG and IgM anti Dengue were negative. Serology IgM TUBEX®TF test for Salmonella typhi was +8. Pediatric Logistic Organ Dysfunction 2 (PELOD 2) score was 10, and pediatric Sequential Organ Failure Assessment (pSOFA) was 5. Based on clinical and laboratory findings, the patient was diagnosed with typhoid fever, sepsis, and DIC.

Table 1.

Laboratory examination during hospitalization.

Laboratory Examination Days of admission
Unit Reference value
1 2 3 4 5 6 7 8 10 13
Leukocyte 7,830 7,140 5,460 3,200 2,280 4,300 4,460 6,710 3,340 cells/μL 4,500–11,500
Lymphocyte 31.3 25.8 31.3 36.6 35.5 20 12.3 11.9 27.2 % 18–42
Neutrophil 62.3 68.4 65.4 59.4 54 60.5 72.5 76.3 67.1 % 50–700
Monocyte 6.4 5.2 2.6 3.1 9.2 18.6 14.1 11.5 5.1 % 0
Eosinophil 0 0 0 0 1.3 0.7 0 0 0 % 0
Basophil 0 0.6 0.7 0.9 0 0.2 1.1 0.3 0.6 % 0
Hemoglobin 7.4 7.1 9.1 8.9 8.7 13.2 12.9 13 11.1 g/dL 12–15
Hematocrite 21 20.3 31.6 26.3 23.9 38 37.1 37.6 32.3 % 35–49
Platelet 75,000 81,000 71,000 48,000 18,000 32,000 25,000 25,000 39,000 cells/μL 150.000–450.000
MCV 75.8 82.5 83.3 82.4 79.9 84.1 84.3 83.4 83 fL 80–94
MCH 26.7 28.9 28.2 27.9 29.1 29.2 29.3 28.8 28.5 pg 26–32
MCHC 35.2 35 33.8 33.8 36.4 34.7 34.8 34.6 34.3 g/dL 32–36
Reticulocyte 0.47 % 0.50–1.50
Procalcitonin 11.98 ng/ml <0.5
Albumin 2.64 3.23 2.68 2.51 1.93 g/dL 3.97–4.94
BUN 7.5 14.1 12.6 37.7 59.9 mg/dL 6–20
Creatinine 0.4 0.15 0.1 0.21 1.33 mg/Dl 0.5–0.9
Glucose 72 106 109 106 97 98 107 mg/dL 80–140
PPT 40.3 17.5 18.7 21.2 19.1 22.6 42.4 second 12.3–15.3
aPTT 83.8 39.8 46.1 47.6 35.8 47.8 63.1 second
Fibrinogen <7 126 143 <8 <8 mg/dL 148–380
D-dimer 10,400 12,840 13,350 12,610 >20,000 ng/mL <230
Anti-Thrombin 3 31 51 49 60 63 % 80–120
AST 4,668 2,742 1,358 1,089 1,252 2,493 U/L <56
ALT 616 390 302 308 296 274 U/L <39
Total bilirubin 4.88 8.97 9.74 11.4 10.68 mg/dL <1.0
Direct bilirubin 4.13 7.66 9.38 8.9 mg/dL 0.0–0.2
Indirect bilirubin 0.75 2.08 2.02 1.78 mg/dL 0.2–0.8
Sodium 134 138 144 134 mmol/L 132–141
Potassium 4.04 3.33 2.89 3.48 mmol/L 3.5–5.1
Chloride 100 103 91 98 mmol/L 97–107
Calcium 1.88 1.74 1.78 1.25 mmol/L 2.15–2.55
Magnesium 2.26 2.09 1.83 1.71 mg/dL 1.60–2.40
Gamma GT 72 U/L <87
Phosphatase Alkaline 287 U/L <409
Ammonia 313.7 μg/dL 27.2–102.0
pH 7.375 7.40 7.43 7.53 7.43 7.42 7.312 mmHg 7.35–7.45
PCO2 32.1 42.8 55.4 43.8 47.2 46.4 33.2 mmHg 35–45
PO2 189 129.9 152.3 187.2 94.1 107.2 102 mmHg 80–95
SO2 100 97.9 98.9 99.5 97.2 97.5 97 % 96–97
BE −6 2 11.9 13.5 6.8 5.9 −9 mmol/L −2 - +3
HCO3 18.8 26.7 37.3 37.3 31.6 30.4 16.6 mmol/L 22–26
OI 3,17 2,69 3.6 2.9 4.7 4.1 3.9
Lactate 5.42 0,99 1.04 5.07 mmol 0.36–1.25
IgG Dengue Negative Negative
IgM Dengue Negative Negative
TUBEX®TF +8 Negative
IgG Leptospira Negative Negative
IgM Leptospira Negative Negative
IgM HAV Negative Negative
HbsAg Negative Negative

The patient was treated with meropenem 40 mg/kgBW/8 hours, dopamine, omeprazole 1 mg/kgBW/12 hours, sucralfate 250 mg/6 hours, furosemide 1 mg/kgBW/8 hours, tranexamic acid 15 mg/kgBW/8 hours, and acetaminophen. DIC management was given (including fresh frozen plasma, platelet concentrate, packed red cells, and antithrombin 3 factors 500 unit). Meropenem was chosen due to history of ceftriaxone and ceftazidime usage in previous hospital.

The patient was hospitalized in a pediatric intensive care unit for 14 days. During hospitalization, temperature instability, hypotension, and massive bleeding were observed. Laboratory examination during hospitalization showed leukocytosis, persistent thrombocytopenia, hypoalbuminemia, coagulation dysfunction, and abnormal liver function (Table 1). Blood culture was performed four times during hospitalization and the results were negative. Blood culture and fecal culture in the second week of fever using gall culture for typhoid were negative. The patient passed away after 14 days of hospitalization due to multiple organ dysfunction syndrome.

3. Discussion

Here, we reported a case of a 4-year-old male patient with typhoid fever and disseminated intravascular coagulation (DIC). Incubation period of Salmonella typhoid is 1–2 weeks. In typical cases, a gradual increase of body temperature, known as “step ladder”, relative bradycardia, and hepatomegaly are common in the first week of onset. Sustained high temperature with apathetic facial expression is observed in the second week of onset. In the third week, intestinal perforation and GIT bleeding are common manifestations. The fourth week is normally the recovery phase. The most common complications due to typhoid infection are hepatitis, bone marrow suppression, and paralytic ileus [5].

The patient's case of typhoid fever was diagnosed using TUBEX®TF with the score being +8, even though blood gall culture test resulted negative in the second week of fever. A positive TUBEX®TF result was defined as a reading of ≥4. TUBEX®TF has 73.0% sensitivity and 69% specificity [6]. Blood culture has limited sensitivity of approximately 40–60%, due to the window for detecting organisms circulating in the bloodstream being usually early in the course of the disease and particularly in the first week of the illness, and the widespread use of antimicrobials [2]. A meta-analysis showed that bone marrow culture has a higher sensitivity rate than blood culture with the sensitivity of 90% [7]. Blood culture in patients after receiving antimicrobials showed less sensitivity than no prior antimicrobial use. Blood volume specimen plays an important role in sensitivity of culture, in which sensitivity increased by 3% (95% CI, 1%–6%) for each additional ml of blood cultured. A 2-mL specimen showed 0.51 (95% CI: 0.44–0.57) and a 10-mL specimen showed 0.65 (95% CI: 0.58–0.70) of sensitivity [7].

Sepsis due to Salmonella typhoid is uncommon [8]. Adu-Gyamfi et al. reported a 28 year-old male with Salmonella sepsis in November 2019. The patient came to hospital and presented with septic shock after a ten-day history of abdominal pain, malaise, vomiting, and diarrhea. Initial laboratory examinations found electrolyte imbalance, leukocytosis, thrombocytosis, and increasing C Reactive Protein level. He had an admission APACHE II of 31 and SOFA score of 10. Patient was operated due to rupture appendix suspicious, intraoperative revealed peritoneal inflammation, primarily in the right iliac region, involving a severely inflamed, thickened terminal ilium, dilated colon, and multiple mesenteric lymph nodes with mildly appendix inflammation without perforation or necrosis. The blood and intra-abdominal specimens isolated S. typhi which was sensitive to ciprofloxacin and the patient improved with it [9]. Another case reported by Nishida et al. was a 7 year-old boy with typhoid fever complicated by sepsis and DIC. Patient presented with fever, diarrhea, vomiting, excessive drowsiness without any underlying disease. Initial laboratory examinations found thrombocytopenia, liver dysfunction, high level of ferritin, and abnormal coagulation with DIC score of 4. Blood culture isolated S. typhi. Patient was treated with ceftriaxone and the patient was clinically improved and discharged in the 14th day of hospitalization [10].

DIC is mostly a subclinical event, and the severe bleeding complications are not typically found in typhoid fever, although DIC score indicates an imbalance of coagulation and fibrinolysis which are markedly elevated in patients with typhoid [11]. Nishida et al. reported a case of typhoid fever complicated by DIC in a 7-year-old male, with acute DIC score of 4, but no sign of bleeding was found [10]. Coagulation problems involve three major processes: pro-coagulation, anti-coagulation, and fibrinolysis. A typhoid patient demonstrates increased plasma prothrombin fragments as well as D-dimer level, prolonged prothrombin time, and lower protein C and anti-thrombin concentrations. Repeated tests of coagulation markers during convalescence showed a return toward normal values [11]. DIC in this patient can be a part of the multi-organ dysfunction due to sepsis syndrome [5].

Acute infection can also result in systemic activation of coagulation. Thrombocytopenia is one of hematological features of typhoid; 18–44.9% of patients with typhoid fever suffer from thrombocytopenia [12]. The mechanism of thrombocytopenia in typhoid patients remains vague. It has been postulated that there are defects in production of platelets due to the direct effect of the toxin produced by Salmonella on the bone marrow, while others have suggested the destruction of non-immune platelets due to DIC [11].

One limitation of our study was the bone marrow culture for typhoid fever was not performed in our patient. Bone marrow culture for typhoid is not a routine protocol in our institution. Bone marrow culture is usually performed if there are negative results of blood and feces culture; unfortunately, our patient passed away before the results of these cultures.

4. Conclusions

Sepsis and DIC are rare complications of typhoid fever. Typhoid fever can be presented with profound bleeding manifestations other than gastrointestinal bleeding, since it is a common symptom of typhoid fever. Further research should be conducted to postulate the association between typhoid fever and DIC.

Ethical Approval

The informed consent form was declared that patient data or samples will be used for educational or research purposes. Our institutional review board also do not provide an ethical approval in the form of case report.

Sources of funding

The authors declare that this study had no funding source.

Author contribution

Nurnaningsih, Vincencius William, Desy Rusmawatiningtyas conceived the study and approved the final draft. Nurnaningsih, Vincencius William, Desy Rusmawatiningtyas, Firdian Makrufardi, Intan Fatah Kumara, drafted the manuscript, and critically revised the manuscript for important intellectual content. Nurnaningsih, Vincencius William, Desy Rusmawatiningtyas, Firdian Makrufardi, Intan Fatah Kumara facilitated all project-related tasks.

Consent

Written informed consent was obtained from the patient's parents for publication of this case report and accompanying images. A copy of the written consent forms is available for review by the Editor-in-Chief of this journal on request.

Registration of Research Studies

This is not a ‘first in humans’ report, so it is not in need of registration.

Guarantor

Nurnaningsih.

Provenance and peer review

Not commissioned, externally peer-reviewed.

Declaration of competing interest

No potential conflict of interest relevant to this article was reported.

Acknowledgment

We want to thank all collaborators of this study.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.amsu.2021.103226.

Contributor Information

Nurnaningsih, Email: nurnaningsih_pri@yahoo.co.id.

Vincencius William, Email: vincencius.william@mail.ugm.ac.id.

Desy Rusmawatiningtyas, Email: desy.rusmawatiningtyas@ugm.ac.id.

Firdian Makrufardi, Email: firdianmakruf@gmail.com.

Intan Fatah Kumara, Email: intan.kumara@gmail.com.

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.docx (29KB, docx)

References

  • 1.World Health Organization . 2018. Typhoid and Other Invasive Salmonellosis; pp. 1–13.https://www.who.int/immunization/monitoring_surveillance/burden/vpd/WHO_SurveillanceVaccinePreventable_21_Typhoid_R1.pdf?ua=1 Available from. [Google Scholar]
  • 2.Parry C.M., Wijedoru L., Arjyal A., Baker S. The utility of diagnostic tests for enteric fever in endemic locations. Expert Rev. Anti Infect. Ther. 2011;9(6):711–725. doi: 10.1586/eri.11.47. [DOI] [PubMed] [Google Scholar]
  • 3.Vollaard A.M., Ali S., Widjaja S., Asten H.A., Visser L.G., Surjadi C., van Dissel J.T. Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 2005 Jun;99(6):440–450. doi: 10.1016/j.trstmh.2004.09.012. [DOI] [PubMed] [Google Scholar]
  • 4.Agha R.A., Franchi T., Sohrabi C., Mathew G., Kerwan A., SCARE Group The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020 Nov 9 doi: 10.1016/j.ijsu.2020.10.034. S1743–S9191. [DOI] [PubMed] [Google Scholar]
  • 5.Malik A.S. Complications of bacteriologically confirmed typhoid fever in children. J. Trop. Pediatr. 2002;48(2):102–108. doi: 10.1093/tropej/48.2.102. [DOI] [PubMed] [Google Scholar]
  • 6.Keddy K.H., Sooka A., Letsoalo M.E., Hoyland G., Chaignat C.L., Morrissey A.B., Crump J.A. Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites. Bull. World Health Organ. 2011;89(9):640–647. doi: 10.2471/BLT.11.087627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Antillon M., Saad N.J., Baker S., Pollard A.J., Pitzer V.E. The relationship between blood sample volume and diagnostic sensitivity of blood culture for typhoid and paratyphoid fever: a systematic review and meta-analysis. J. Infect. Dis. 2018;218(4):S255–S267. doi: 10.1093/infdis/jiy471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ray B., Raha A. Typhoid and enteric fevers in intensive care unit. Indian J. Crit. Care Med. 2021 May;25(Suppl 2):S144–S149. doi: 10.5005/jp-journals-10071-23842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Adu-Gyamfi R., Hoosain F., Chetty S. Salmonella typhi: a quiet bacteria with a loud message: an ICU case report. Bali J Anesthesiol. 2019;3(2):129–132. doi: 10.15562/bjoa.v3i2.161. [DOI] [Google Scholar]
  • 10.Huang G.C., Chang C.M., Ko W.C., Huang Y.L., Chuang Y.C. Typhoid fever complicated by multiple organ involvement: report of two cases. J. Infect. 2005 Aug;51(2):E57–E60. doi: 10.1016/j.jinf.2004.08.018. [DOI] [PubMed] [Google Scholar]
  • 11.de Jong H.K., Parry C.M., van der Vaart T.W., Kager L.M., van den Ende S.J., Maude R.R., Wijedoru L., Ghose A., Hassan M.U., Hossain M.A., Dondorp A.M., Baker S., Faiz M.A., Meijers J.C.M., Wiersinga W.J. Activation of coagulation and endothelium with concurrent impairment of anticoagulant mechanisms in patients with typhoid fever. J. Infect. 2018 Jul;77(1):60–67. doi: 10.1016/j.jinf.2018.03.008. [DOI] [PubMed] [Google Scholar]
  • 12.Getahun Strobel A., Parry C.M., Crump J.A., Rosa V., Jenney A., Naidu R., Mulholland K., Strugnell R.A. A retrospective study of patients with blood culture-confirmed typhoid fever in Fiji during 2014-2015: epidemiology, clinical features, treatment and outcome. Trans. R. Soc. Trop. Med. Hyg. 2019;113(12):764–770. doi: 10.1093/trstmh/trz075. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (29KB, docx)

Articles from Annals of Medicine and Surgery are provided here courtesy of Wolters Kluwer Health

RESOURCES